Literature DB >> 21545235

Polycomb group protein Bmi1 promotes hematopoietic cell development from embryonic stem cells.

Xiaolei Ding1, Qiong Lin, Roberto Ensenat-Waser, Stefan Rose-John, Martin Zenke.   

Abstract

Bmi1 is a component of the Polycomb repressive complexes and essential for maintaining the pool of adult stem cells. Polycomb repressive complexes are key regulators for embryonic development by modifying chromatin architecture and maintaining gene repression. To assess the role of Bmi1 in pluripotent stem cells and on exit from pluripotency during differentiation, we studied forced Bmi1 expression in mouse embryonic stem cells (ESC). We found that ESC do not express detectable levels of Bmi1 RNA and protein and that forced Bmi1 expression had no obvious influence on ESC self-renewal. However, upon ESC differentiation, Bmi1 effectively enhanced development of hematopoietic cells. Global transcriptional profiling identified a large array of genes that were differentially regulated during ESC differentiation by Bmi1. Importantly, we found that Bmi1 induced a prominent up-regulation of Gata2, a zinc finger transcription factor, which is essential for primitive hematopoietic cell generation from mesoderm. In addition, Bmi1 caused sustained growth and a >100-fold expansion of ESC-derived hematopoietic stem/progenitor cells within 2-3 weeks of culture. The enhanced proliferative capacity was associated with reduced Ink4a/Arf expression in Bmi1-transduced cells. Taken together, our experiments demonstrate distinct activities of Bmi1 in ESC and ESC-derived hematopoietic progenitor cells. In addition, Bmi1 enhances the propensity of ESC in differentiating toward the hematopoietic lineage. Thus, Bmi1 could be a candidate gene for engineered adult stem cell derivation from ESC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21545235     DOI: 10.1089/scd.2010.0539

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  9 in total

1.  The polycomb protein Ezh2 impacts on induced pluripotent stem cell generation.

Authors:  Xiaolei Ding; Xiaoying Wang; Stephanie Sontag; Jie Qin; Paul Wanek; Qiong Lin; Martin Zenke
Journal:  Stem Cells Dev       Date:  2014-01-21       Impact factor: 3.272

Review 2.  Epigenetics of hematopoiesis and hematological malignancies.

Authors:  Deqing Hu; Ali Shilatifard
Journal:  Genes Dev       Date:  2016-09-15       Impact factor: 11.361

3.  Splitomicin, a SIRT1 Inhibitor, Enhances Hematopoietic Differentiation of Mouse Embryonic Stem Cells.

Authors:  Jeong-A Park; Sangkyu Park; Woo-Youn Park; Myung-Kwan Han; Younghee Lee
Journal:  Int J Stem Cells       Date:  2019-03-30       Impact factor: 2.500

4.  Polycomb group protein Bmi1 is required for the neuronal differentiation of mouse induced pluripotent stem cells.

Authors:  Wei Shan; Liping Zhou; Lizhen Liu; Deju Lin; Qin Yu
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

Review 5.  Epigenetic regulation of hematopoietic stem cell homeostasis.

Authors:  Penglei Jiang; Hui Wang; Jiachen Zheng; Yingli Han; He Huang; Pengxu Qian
Journal:  Blood Sci       Date:  2019-09-17

6.  High-Throughput siRNA Screening to Reveal GATA-2 Upstream Transcriptional Mechanisms in Hematopoietic Cells.

Authors:  Yo Saito; Tohru Fujiwara; Keiichi Ohashi; Yoko Okitsu; Noriko Fukuhara; Yasushi Onishi; Kenichi Ishizawa; Hideo Harigae
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

Review 7.  Epigenetic mechanisms of tumorigenicity manifesting in stem cells.

Authors:  P-Y Tung; P S Knoepfler
Journal:  Oncogene       Date:  2014-06-16       Impact factor: 9.867

8.  The Hemogenic Competence of Endothelial Progenitors Is Restricted by Runx1 Silencing during Embryonic Development.

Authors:  Alexia Eliades; Sarah Wareing; Elli Marinopoulou; Muhammad Z H Fadlullah; Rahima Patel; Joanna B Grabarek; Berenika Plusa; Georges Lacaud; Valerie Kouskoff
Journal:  Cell Rep       Date:  2016-05-26       Impact factor: 9.423

Review 9.  Polycomb complexes in normal and malignant hematopoiesis.

Authors:  Valerio Di Carlo; Ivano Mocavini; Luciano Di Croce
Journal:  J Cell Biol       Date:  2018-10-19       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.